APA (7th ed.) Citation

C, Y., L, T., L, Z., I, K., J, L., S, S., . . . E, C. (2026). Minimal Clinically Important Differences to Determine Meaningful Change in the Skin Symptom Assessment (SSA) Questionnaire for the Randomized Controlled Trial of Mepitel Film Versus Standard of Care for the Prevention of Acute and Chronic Dermatitis in Breast Cancer Radiation Treatment. Clinical breast cancer, 26(8), 31. https://doi.org/10.1016/j.clbc.2026.06.005

Chicago Style (17th ed.) Citation

C, Yang, et al. "Minimal Clinically Important Differences to Determine Meaningful Change in the Skin Symptom Assessment (SSA) Questionnaire for the Randomized Controlled Trial of Mepitel Film Versus Standard of Care for the Prevention of Acute and Chronic Dermatitis in Breast Cancer Radiation Treatment." Clinical Breast Cancer 26, no. 8 (2026): 31. https://doi.org/10.1016/j.clbc.2026.06.005.

MLA (9th ed.) Citation

C, Yang, et al. "Minimal Clinically Important Differences to Determine Meaningful Change in the Skin Symptom Assessment (SSA) Questionnaire for the Randomized Controlled Trial of Mepitel Film Versus Standard of Care for the Prevention of Acute and Chronic Dermatitis in Breast Cancer Radiation Treatment." Clinical Breast Cancer, vol. 26, no. 8, 2026, p. 31, https://doi.org/10.1016/j.clbc.2026.06.005.